← FDA DRUG APPROVALS

FDA ANDA · ANDA062811

CLINDAMYCIN PHOSPHATE

Sponsor: G AND W LABS INC

APPLICATION
ANDA062811
TYPE
ANDA
ORIGINAL APPROVAL
1988-09-01
LATEST ACTION
2016-06-01
ROUTE
TOPICAL
DOSAGE FORM
SOLUTION
MARKETING STATUS
Discontinued

Products

CLINDAMYCIN PHOSPHATEDiscontinued
CLINDAMYCIN PHOSPHATE EQ 1% BASE · SOLUTION · TOPICAL

Approval history

2016-06-01Labeling · Supplement 20 · standardAP
2016-06-01Labeling · Supplement 19 · standardAP
2016-06-01Labeling · Supplement 18 · standardAP
2014-11-14Manufacturing (CMC) · Supplement 17AP
2002-11-20Manufacturing (CMC) · Supplement 10AP
2001-02-08Manufacturing (CMC) · Supplement 8AP
2001-01-22Manufacturing (CMC) · Supplement 6AP
2001-01-22Manufacturing (CMC) · Supplement 7AP
2001-01-17Manufacturing (CMC) · Supplement 9AP
2000-10-03Manufacturing (CMC) · Supplement 5AP
1997-11-12Manufacturing (CMC) · Supplement 4AP
1996-09-23Manufacturing (CMC) · Supplement 2AP
1994-06-23Manufacturing (CMC) · Supplement 1AP
1988-09-01OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →